Left to their own devices
Scandals, recalls, stingy customers, anxious regulators--any one of these would traumatise a chief executive. America's industry for medical devices is suffering from all of them. Omar Ishrak, the new boss of Medtronic, the world's biggest medical-technology company, recently described the problem succinctly to analysts: "There is a lot of work ahead of us." This is a relatively new ailment for the industry. From 1998 to 2005 the use of equipment such as defibrillators and drug-eluting stents expanded rapidly. "It was the age of implantation in this country," explains David Lewis of Morgan Stanley, with companies "sticking things into everybody." Much has changed.
- As Retail Clinics Surge, Quality Metrics MIA
- Providers' Push to Consolidate Roils Payers
- Medicare Cost, Quality Data Tools Weak, Says GAO
- No Employee Satisfaction, No Patient-Centered Culture
- RN Named Chief Patient Experience Officer
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- Population Health Pays Off for NY Collaborative
- How Simple Data Analytics is Driving Physician Incentives
- AMA Pushes Lame Duck Congress for SGR Repeal
- In PCMH, the 'P' is Not for 'Physician'